OTC · Biotechnology

Kaleido Biosciences, Inc. (KLDO) Stock

$0.00 OTC: KLDO Healthcare

Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to pioneering microbiome metabolic therapies.

Valuation

MetricValue
Price$0.00
Market Cap$426
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-0.22
52-Week High$0.20
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-580.57%
ROA-99.93%
ROCE-428.58%
Gross Margin-8800.00%
Operating Margin-8800.00%
Net Margin-9000.00%
Debt/Equity2.05
Current Ratio1.43

Annual Financials (USD)

Metric20172018201920202021
Revenue$0$0$0$1.0M$1.0M
Operating Profit$-27.0M$-61.0M$-87.0M$-79.0M$-88.0M
Net Profit$-28.0M$-62.0M$-85.0M$-82.0M$-90.0M
EPS$-1.23$-2.10$-3.31$-2.44$-2.16
Op Margin———-8089.6%-7940.9%

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$31.0M$85.0M$82.0M$59.0M$50.0M
Total Liabilities$74.0M$27.0M$33.0M$39.0M$40.0M
Cash$28.0M$76.0M$71.0M$46.0M$38.0M
Borrowings$15.0M$15.0M$20.0M$21.0M$22.0M

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$-22.0M$-46.0M$-76.0M$-62.0M$-77.0M
Investing Cash Flow$-3.0M$-6.0M$-7.0M$-8.0M$-2.0M
Financing Cash Flow$3.0M$-2.0M$-1.0M$3.0M$0
Net Cash Flow$26.0M$50.0M$-5.0M$-25.0M$-8.0M
Free Cash Flow$-24.0M$-49.0M$-79.0M$-66.0M$-78.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.20
FCF Yield-18362206.57%
Quick Ratio1.43
Interest Coverage-30.89
Return 1Y-90.00%
Return 3Y-90.00%
Return 5Y-100.00%

Ownership

Insiders Held0.00%
Institutions Held0.06%
Institutions Float Held0.06%
Institutional HolderSharesReport Date
Bay Harbor Wealth Management, LLC2,3002026-06-30
Hantz Financial Services, Inc. 3502026-03-31
Rmg Wealth Management LLC702026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARNIArno Therapeutics, Inc. $0.00 — 0.00 $4935 0.00%
BTTXBetter Therapeutics, Inc. $0.00 — 0.00 $5452 0.00%
BXRXQBaudax Bio, Inc. $0.00 — 0.00 $4359 0.00%
CALACalithera Biosciences, Inc. $0.00 — 0.00 $487 0.00%
IVBTInnovation1 Biotech Inc. $0.00 — 0.00 $4494 0.00%

About Kaleido Biosciences, Inc.

Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to pioneering microbiome metabolic therapies. Its pipeline includes specific drug candidates such as KB195 for urea cycle disorders, KB295 targeting ulcerative colitis, KB174 aimed at hepatic encephalopathy, and KB109 for COVID-19. The company is also advancing programs in other significant therapeutic areas, including multi-drug resistant infections, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and various inflammatory bowel conditions. Kaleido maintains strategic collaborations with Institute Gustave Roussy, Washington University, and Janssen. Established in 2015, its headquarters are situated in Lexington, Massachusetts.

Kaleido Biosciences, Inc. (KLDO) stock trades at $0.00 with a market capitalization of $426. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.20, and currently trades 100.0% below its 52-week high.

On profitability, Kaleido Biosciences, Inc. generates a return on equity (ROE) of -580.57%, return on capital employed of -428.58%, an operating margin of -8800.00%, a net profit margin of -9000.00%.

Official website: kaleido.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides